SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-04-002788
Filing Date
2004-07-19
Accepted
2004-07-19 07:49:01
Documents
9
Period of Report
2004-07-16
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w99186e8vk.htm 8-K 11503
2 EXHIBIT 99.1 w99186exv99w1.htm EX-99.1 17654
3 EXHIBIT 99.2 w99186exv99w2.htm EX-99.2 102014
4 EXHIBIT 99.3 w99186exv99w3.htm EX-99.3 182508
5 EXHIBIT 99.4 w99186exv99w4.htm EX-99.4 155092
6 EXHIBIT 99.5 w99186exv99w5.htm EX-99.5 142292
7 EXHIBIT 99.6 w99186exv99w6.htm EX-99.6 28342
8 GRAPHIC w99186w9918600.gif GRAPHIC 2026
9 GRAPHIC w99186w9918601.gif GRAPHIC 5550
  Complete submission text file 0000950133-04-002788.txt   649521
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 04919110
SIC: 2836 Biological Products, (No Diagnostic Substances)